CCM
BSX icon

Chiron Capital Management’s Boston Scientific BSX Stock Holding History

Chiron Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$811K Buy
+19,001
New +$1.03M 0.73% 42

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Chiron Capital Management's BSX Position: Q2 2026 in Review

Chiron Capital Management opened a new position in Boston Scientific (BSX) in Q2 2026: 19,001 shares worth $811K. The stake represents 0.73% of the portfolio and ranks #42 among its holdings.

241 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Chiron Capital Management held 19,001 shares of Boston Scientific worth $811K as of Q2 2026.
  • Boston Scientific was a new Chiron Capital Management position in Q2 2026.
  • Boston Scientific made up 0.73% of Chiron Capital Management's portfolio in Q2 2026, its #42 holding.
  • 241 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.